ConductScience.org, home

Paper8690751

Preferential cytotoxic effect of Newcastle disease virus on lymphoma cells.

Bar-Eli N and 3 others. J Cancer Res Clin Oncol, 1996. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Preferential cytotoxic effect of Newcastle disease virus on lymphoma cells. Papers, record 8690751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8690751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Preferential cytotoxic effect of Newcastle disease virus on lymphoma cells.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
1996
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
0.69
iCite
Revised in PubMed
2025-07-19
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bar-Eli NN
2Giloh HH
3Schlesinger MM
4Zakay-Rones ZZ

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Burkitt LymphomaMajor topic
Lymphoma, B-CellMajor topic
Newcastle disease virusMajor topic
Cell Membrane Permeability
Cell Transformation, Viral
Chromium
Chromium Radioisotopes
Cytotoxicity, Immunologic
DNA, Neoplasm
Humans
Lymphocyte Activation
Lymphocytes
Phytohemagglutinins
Pokeweed Mitogens
Sensitivity and Specificity
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17954437Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy.Cancer Res1994https://conductscience.org/library/papers/7954437PubMed
24133080Lymphocyte receptors for myxoviruses and paramyxoviruses.J Immunol1974https://conductscience.org/library/papers/4133080PubMed
32921273Sensitivity of Burkitt lymphoma Daudi cells to inactive influenza virus.J Cancer Res Clin Oncol1989https://conductscience.org/library/papers/2921273PubMed
414147810EFFECT OF ACTIVE AND ULTRAVIOLET-IRRADIATED INACTIVE VACCINIA VIRUS ON THE DEVELOPMENT OF SHAY LEUKEMIA IN RATS.Cancer Res1964https://conductscience.org/library/papers/14147810PubMed
52462467Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation.Cancer Immunol Immunother1989https://conductscience.org/library/papers/2462467PubMed
62474832Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2474832PubMed
7126271Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes.J Exp Med1975https://conductscience.org/library/papers/126271PubMed
88515058Characterization of a novel cell-surface molecule expressed on subpopulations of activated T and B cells.J Immunol1993https://conductscience.org/library/papers/8515058PubMed
91744162Killing of Burkitt-lymphoma-derived Daudi cells by ultraviolet-inactivated vaccinia virus.J Cancer Res Clin Oncol1991https://conductscience.org/library/papers/1744162PubMed
102459402Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity.J Natl Cancer Inst1988https://conductscience.org/library/papers/2459402PubMed
118275514Attenuated veterinary virus vaccine for the treatment of cancer.Cancer Detect Prev1993https://conductscience.org/library/papers/8275514PubMed
13221925Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/221925PubMed
143030235Viruses as toxins. With special reference to paramyxoviruses. Brief review.Arch Virol1987https://conductscience.org/library/papers/3030235PubMed
154577688Participation of lymphocytes in viral infections.Adv Immunol1973https://conductscience.org/library/papers/4577688PubMed
162302742Modification of tumor cells by a low dose of Newcastle disease virus. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon-alpha/beta.Cell Immunol1990https://conductscience.org/library/papers/2302742PubMed
172751555Elevated virulence of Newcastle disease virus strains following serial passages in kidney cells in vitro.Avian Dis1989https://conductscience.org/library/papers/2751555PubMed
182183871Tumour necrosis factor: a cytokine with multiple biological activities.Br J Cancer1990https://conductscience.org/library/papers/2183871PubMed
192419962Arrest of Daudi cell growth by inactive influenza virus in-vitro.Scan Electron Microsc1985https://conductscience.org/library/papers/2419962PubMed
20838573Iodination fo Newcastle disease virus envelope proteins with lactoperoxidase.Isr J Med Sci1977https://conductscience.org/library/papers/838573PubMed
214174339Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.Cancer Res1968https://conductscience.org/library/papers/4174339PubMed

See all 29 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
42871809Therapeutic potential of oncolytic viruses in hematopoietic malignancies: from preclinical insights to clinical realities.Front Microbiol2026https://conductscience.org/library/papers/42871809PubMed
40567544Oncolytic potential of Newcastle Disease Virus in feline lymphoma cells: an in vitro evaluation.Front Vet Sci2025https://conductscience.org/library/papers/40567544PubMed
36217339Oncolytic Viruses in the Therapy of Lymphoproliferative Diseases.Mol Biol2022https://conductscience.org/library/papers/36217339PubMed
34150610Differential microRNA Expression in Newcastle Disease Virus-Infected HeLa Cells and Its Role in Regulating Virus Replication.Front Oncol2021https://conductscience.org/library/papers/34150610PubMed
32078405Recent advances of oncolytic virus in cancer therapy.Hum Vaccin Immunother2020https://conductscience.org/library/papers/32078405PubMed
29949934Fusogenic Viruses in Oncolytic Immunotherapy.Cancers (Basel)2018https://conductscience.org/library/papers/29949934PubMed
27579294Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy.Oncolytic Virother2016https://conductscience.org/library/papers/27579294PubMed
27512670Therapeutic potential of oncolytic Newcastle disease virus: a critical review.Oncolytic Virother2015https://conductscience.org/library/papers/27512670PubMed
26703717Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma.Viruses2015https://conductscience.org/library/papers/26703717PubMed
26640815Oncolysis by paramyxoviruses: preclinical and clinical studies.Mol Ther Oncolytics2015https://conductscience.org/library/papers/26640815PubMed
22393889Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.Future Microbiol2012https://conductscience.org/library/papers/22393889PubMed
21740354Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.Curr Pharm Biotechnol2012https://conductscience.org/library/papers/21740354PubMed
20237963Cancer stem cells: the final frontier for glioma virotherapy.Stem Cell Rev Rep2011https://conductscience.org/library/papers/20237963PubMed
19643532Virotherapy against malignant glioma stem cells.Cancer Lett2010https://conductscience.org/library/papers/19643532PubMed
18535620Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors.Cancer Gene Ther2008https://conductscience.org/library/papers/18535620PubMed
10759404Oncolytic viruses.Invest New Drugs1999https://conductscience.org/library/papers/10759404PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8690751

GET https://conductscience.org/api/papers/v1/8690751/references?page=2